Chiara Gabbiani - Search Results

Year	Number of Results
2004	2
2005	4
2006	5
2007	10
2008	9
2009	7
2010	14
2011	11
2012	9
2013	6
2014	6
2015	3
2016	4
2017	5
2018	4
2019	2
2020	5
2021	2
2022	2
2023	3
2024	1

1

A focus on the biological targets for coinage metal-NHCs as potential anticancer complexes.

Guarra F, Pratesi A, Gabbiani C, Biver T. Guarra F, et al. Among authors: gabbiani c. J Inorg Biochem. 2021 Apr;217:111355. doi: 10.1016/j.jinorgbio.2021.111355. Epub 2021 Jan 20. J Inorg Biochem. 2021. PMID: 33596529 Review.

2

Protein targets for anticancer gold compounds: mechanistic inferences.

Gabbiani C, Messori L. Gabbiani C, et al. Anticancer Agents Med Chem. 2011 Dec;11(10):929-39. doi: 10.2174/187152011797927607. Anticancer Agents Med Chem. 2011. PMID: 21864237 Review.

3

cis-Pt I2(NH3)2: a reappraisal.

Marzo T, Pillozzi S, Hrabina O, Kasparkova J, Brabec V, Arcangeli A, Bartoli G, Severi M, Lunghi A, Totti F, Gabbiani C, Quiroga AG, Messori L. Marzo T, et al. Among authors: gabbiani c. Dalton Trans. 2015 Sep 7;44(33):14896-905. doi: 10.1039/c5dt01196e. Dalton Trans. 2015. PMID: 26226326

4

Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments.

Giorgi E, Binacchi F, Marotta C, Cirri D, Gabbiani C, Pratesi A. Giorgi E, et al. Among authors: gabbiani c. Molecules. 2022 Dec 29;28(1):273. doi: 10.3390/molecules28010273. Molecules. 2022. PMID: 36615466 Free PMC article. Review.

5

Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies.

Nobili S, Mini E, Landini I, Gabbiani C, Casini A, Messori L. Nobili S, et al. Among authors: gabbiani c. Med Res Rev. 2010 May;30(3):550-80. doi: 10.1002/med.20168. Med Res Rev. 2010. PMID: 19634148 Review.

6

Proteomic and metallomic strategies for understanding the mode of action of anticancer metallodrugs.

Gabbiani C, Magherini F, Modesti A, Messori L. Gabbiani C, et al. Anticancer Agents Med Chem. 2010 May;10(4):324-37. doi: 10.2174/187152010791162315. Anticancer Agents Med Chem. 2010. PMID: 20380635 Review.

7

Biophysical characterisation of adducts formed between anticancer metallodrugs and selected proteins: new insights from X-ray diffraction and mass spectrometry studies.

Casini A, Guerri A, Gabbiani C, Messori L. Casini A, et al. Among authors: gabbiani c. J Inorg Biochem. 2008 May-Jun;102(5-6):995-1006. doi: 10.1016/j.jinorgbio.2007.12.022. Epub 2008 Jan 8. J Inorg Biochem. 2008. PMID: 18289690 Review.

8

Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives.

Navarro M, Gabbiani C, Messori L, Gambino D. Navarro M, et al. Among authors: gabbiani c. Drug Discov Today. 2010 Dec;15(23-24):1070-8. doi: 10.1016/j.drudis.2010.10.005. Epub 2010 Oct 23. Drug Discov Today. 2010. PMID: 20974285 Review.

9

First Crystal Structure for a Gold Carbene-Protein Adduct.

Ferraro G, Gabbiani C, Merlino A. Ferraro G, et al. Among authors: gabbiani c. Bioconjug Chem. 2016 Jul 20;27(7):1584-7. doi: 10.1021/acs.bioconjchem.6b00298. Epub 2016 Jul 6. Bioconjug Chem. 2016. PMID: 27364343 Free article.

10

Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent.

Cirri D, Massai L, Giacomelli C, Trincavelli ML, Guerri A, Gabbiani C, Messori L, Pratesi A. Cirri D, et al. Among authors: gabbiani c. Dalton Trans. 2022 Sep 13;51(35):13527-13539. doi: 10.1039/d2dt00836j. Dalton Trans. 2022. PMID: 36000524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

102 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year